Voloridge Investment Management, LLC Biomarin Pharmaceutical Inc Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 48,340 shares of BMRN stock, worth $3.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

48,340

Previous 6,473 646.79%

Holding current value

$3.22 Million

Previous $532,000 538.53%

% of portfolio

0.01%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $2.89 Million - $3.93 Million	41,867 Added 646.79%	48,340 $3.4 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $481,785 - $596,940	6,473 New	6,473 $532,000
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $4.07 Million - $5.47 Million	50,336 New	50,336 $5.21 Million
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $285,903 - $356,763	-3,849 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $276,050 - $352,068	3,849 New	3,849 $340,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $2.39 Million - $2.74 Million	-32,017 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $1.62 Million - $1.82 Million	-21,510 Reduced 40.19%	32,017 $2.67 Million
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $4 Million - $4.85 Million	53,527 New	53,527 $4.04 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $591,626 - $734,949	-8,148 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $88,903 - $162,084	-1,237 Reduced 13.18%	8,148 $620,000
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $3.64 Million - $5.68 Million	-45,752 Reduced 82.98%	9,385 $1.16 Million
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $3.94 Million - $5.34 Million	55,137 New	55,137 $4.66 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Biomarin Pharmaceutical Inc Transaction History